Download PDF
Nuklearmedizin 2021; 60(03): 252-253
DOI: 10.1055/a-1312-6148
Case Report

68Ga-PSMA Uptake in Pulmonary Tuberculosis: A Pitfall in Prostate Cancer PET Imaging

68Ga-PSMA-Aufnahme bei Lungentuberkulose: Ein Fallstrick in der Prostatakrebs-PET-Bildgebung
Huijuan Liu
1   Department of Intensive Care Unit, Jiangan Hospital of Traditional Chinese Medicine, Yibin, Sichuan, PR China, Yibin, China
,
Yuhong Liu
2   Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University/Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, Sichuan, PR China, Luzhou, China
,
Yue Chen
2   Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University/Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, Sichuan, PR China, Luzhou, China
,
Huipan Liu
2   Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University/Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, Sichuan, PR China, Luzhou, China
› Author Affiliations
› Further Information
    Permissions and Reprints

Introduction

68Ga-PSMA ligand PET/CT is a novel imaging modality for prostate cancer. Nevertheless, PSMA expression has been detected in various solid tumors including lung adenocarcinoma. It is not rare for prostate cancer to metastasize to the lung, and it is difficult to differentiate primary lung lesions from metastatic prostate cancer to the lung, especially when there is a focal PSMA uptake in the lung lesion [1]. Here we report a case of prostate cancer with intensive PSMA expression in pulmonary tuberculosis.



Publication History

Article published online:
10 December 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Usmani S, Sadeq A, Marafi F. et al. 68Ga-PMSA Uptake in the Lung: Metastatic Versus Primary Lung Tumor. Clinical nuclear medicine 2020; 45: e80-e82
    CrossrefPubMedGoogle Scholar
  • 2 Sheikhbahaei S, Afshar-Oromieh A, Eiber M. et al. Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging. European journal of nuclear medicine and molecular imaging 2017; 44: 2117-2136
    CrossrefPubMedGoogle Scholar
  • 3 Pyka T, Weirich G, Einspieler I. et al. 68Ga-PSMA-HBED-CC PET for Differential Diagnosis of Suggestive Lung Lesions in Patients with Prostate Cancer. J Nucl Med 2016; 57: 367-371
    CrossrefPubMedGoogle Scholar
  • 4 Damjanovic J, Janssen JC, Furth C. et al. (68)Ga-PSMA-PET/CT for the evaluation of pulmonary metastases and opacities in patients with prostate cancer. Cancer Imaging 2018; 18: 20
    CrossrefPubMedGoogle Scholar
  • 5 Liepe K, Baehr M, Kuhn B. False-positive findings in inflammatory processes using 99mTc-PSMA. Nuklearmedizin 2020; DOI: 10.1055/a-1233-8523.
    Article in Thieme ConnectPubMedGoogle Scholar